Market pulse › Eli Lilly
Eli Lilly
Today1 story · 1 articles
Net tone● ±0% today
Market checkNovartis India −0.3%
Developing0 storylines
325 Sept
126 Sept
127 Sept
028 Sept
Market move● mixedHere are the 4 big things we're watching in the stock market in the week aheadUS Fed dual mandate is in focus, alongside Micron results and Eli Lilly obesity-pipeline updatesUS FedMicronInflation
Legal● mixedRs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly oppose a Kerala High Court petition seeking government intervention to lower breast cancer drug pricesPharma and healthcareNovartis India
Expansion● mixedNovo is betting on its next chapter as Eli Lilly gains more ground in GLP-1sAnalysts say Lilly may have advantages as Novo tries to regain ground in the obesity drug marketPharma and healthcareNovo Nordisk
● mixedThe Peptide Boom That Isn’t About Your MusclesThe opportunity is pill-form peptides that could challenge big pharma’s most profitable franchisesPharma and healthcareNovo Nordisk
Deal● mixedAfter capital-markets day flop, Novo strikes licensing deal that sends a Swedish company’s stock soaringNovo Nordisk struck a licensing deal worth over $1 billionNovo NordiskPharma and healthcareEuropean markets